[1]
“Medication Persistence in Heart Failure with Coronary Artery Disease: A Pharmacoeconomic Analysis of Cost-Effectiveness and Cost-Drivers in Indonesia”, Gema Lingkungan Kesehatan, vol. 24, no. 4, pp. 666–676, Nov. 2026, doi: 10.36568/gelinkes.v24i4.589.